Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TEM
SellHot AirTempus AI, Inc. · Healthcare · United States · $11.6B · Avg Vol: $421M/d
COMPANY DESCRIPTION
Tempus AI, Inc. is a technology company focused on advancing precision medicine by collecting and analyzing large volumes of molecular and clinical data. It provides physicians with data-driven insights and tools to make informed treatment decisions, particularly in oncology and other complex diseases, through its AI-powered platform. Tempus holds a niche market position as a leader in real-world data and genomic sequencing for healthcare, facilitating personalized medicine and drug discovery.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 320.7M | 531.8M | 693.4M | 1.3B | 58.3% | 1.4B | 1.6B | 2.0B | 24.5% |
| EPS | -5.26 | -1.61 | -6.23 | -1.41 | — | -1.44 | — | — | — |
| Shares | 164.8M | 164.8M | 162.0M | 178.3M | +8.2% | 175.4M | — | — | — |
| Debt | 433.0M | 488.1M | 468.1M | 1.3B | 45.3% | 1.4B | — | — | — |
| Equity | -1.1B | -1.4B | 56.3M | 491.3M | 772.1% | — | — | — | — |
| Op CF | -168.2M | -214.3M | -189.0M | -218.1M | — | -237.4M | — | — | — |
| Inv CF | -57.9M | -40.3M | -130.4M | -398.4M | — | — | — | — | — |
| Fin CF | 251.4M | 117.5M | 494.3M | 884.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TEM are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TEM | Tempus AI, Inc.(you) | $11.6B | 31 | Sell |
| HTFL | Heartflow, Inc. | $4.2B | 44 | Hold |
| TXG | 10x Genomics, Inc. | $8.0B | 60 | Hold |
| SDGR | Schrödinger, Inc. | $1.5B | 36 | Hold |
| DOCS | Doximity, Inc. | $4.8B | 61 | Hold |
| WAY | Waystar Holding Corp. | $5.0B | 62 | Hold |
| PRVA | Privia Health Group, Inc. | $2.7B | 51 | Hold |
| BTSG | BrightSpring Health Services, Inc. | $11.7B | 84 | Strong Buy |
| HQY | HealthEquity, Inc. | $8.0B | 82 | Strong Buy |
| CERT | Certara, Inc. | $1.3B | 48 | Hold |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%